Stewart ZA, Wilinska ME, Hartnell S et al (2018) Day-and-night closed-loop insulin delivery in a broad population of pregnant women with type 1 diabetes: a randomized controlled crossover trial
External resources The Lancet: Effects of retatrutide on body composition in people with type 2 diabetes New England Journal of Medicine: Triple-Hormone-Receptor Agonist Retatrutide for Obesity PMC: Saving muscle while losing weight on GLP-1 related drugs In case I do not see you, good afternoon, good evening, and good night
Our treatment is a once-weekly injection, and a synthetic GLP-1 RA (receptor agonist)
Earlier this year, they reported the identification of a series of biomarker signatures that can quantitatively predict which patients are most likely to respond to GLP-1 therapies and sustain that response over time
These products may be counterfeit, incorrectly dosed, or supplied without proper medical supervision